Groprinosin syrup 250mg / 5ml 120 ml vial INOSINUM Гропринозин

Groprinosin Indications

- Infectious disease of viral etiology in patients with normal and reduced immune status,

influenza,

parainfluenza,

acute respiratory infections,

bronchitis,

viral etiology,

rhinovirus and adenovirus infection,

mumps,

measles (hard or complicated);

- Diseases caused by herpes simplex virus type I Herpes simplex or Herpes simplex type II (herpes lips, skin, oral mucosa, skin, ophthalmoherpes),

subacute sclerosal panentsefalit, genital herpes;

virus Varicella zoster (chickenpox and shingles, including recurrent in patients with immunodeficiency);

Epstein - Barr virus (infectious mononucleosis) cytomegalovirus;

human papillomavirus; acute and chronic hepatitis B;

- Chronic recurrent respiratory tract infections and urinary system in patients with weakened immune systems (including chlamydia and other diseases caused by intracellular pathogens).

Contraindications

- Hypersensitivity to the active substance or to any of the excipients of the drug;

- Acute attack of gout;

- Hyperuricemia.

Dosage & Administration

The drug is taken orally, preferably after meals, at regular intervals. Duration of treatment is determined individually, depending on nosology, severity and frequency of relapses process; the average duration of treatment is 5-14 days, if necessary after 7 -10-day break, repeat the treatment. Treatment of interruptions and maintenance doses may take up to 1-6 months.

Adult applied Hroprynozyn tablets of 500 mg.

The maximum daily dose for adults - 80 ml syrup or 8 tablets 500 mg (4 grams inosine pranobex).